Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Prednisolone to Prevent Infantile Spasms Relapse
NCT06819670Phase 2Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- May 2025
- Primary completion
- Feb 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone in infantile epileptic spasms syndrome (IESS), sponsored by University of California, Los Angeles. Started May 2025; status: recruiting.
02
Drugs
prednisolone
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT06819670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819670.